GO:0038084 vascular endothelial growth factor signaling pathway: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0038084 describes the molecular signaling cascade triggered when vascular endothelial growth factor (VEGF) binds its receptor on the target cell surface, culminating in regulation of downstream cellular processes such as transcription.
• The pathway is initiated by VEGF ligands (VEGFA, VEGFB, VEGFC, VEGFD, PlGF) binding to receptor tyrosine kinases VEGFR1, VEGFR2, and VEGFR3, with VEGFR2 being the principal mediator of angiogenic responses.
• Core downstream signaling includes receptor autophosphorylation, PLCγ-PKC-ERK1/2 activation, PI3K-AKT-eNOS signaling, and Src-mediated pathways that together drive endothelial cell proliferation, migration, survival, and permeability.
• VEGF signaling is essential for embryonic vascular development and adult physiological angiogenesis, but its dysregulation contributes to cancer, retinopathies, and inflammatory diseases.
• MicroRNAs and other regulatory layers fine-tune VEGF signaling output during vascular development, providing additional targets for experimental manipulation.
• CRISPR-based knockout, knock-in, and overexpression models enable causal dissection of VEGF pathway components in endothelial cells and disease models.
Description
The vascular endothelial growth factor signaling pathway (GO:0038084) is a biological process defined as the series of molecular signals initiated by VEGF binding its receptor on the surface of a target cell and ending with regulation of a downstream cellular process, such as transcription. This pathway is a central regulator of angiogenesis, lymphangiogenesis, and vascular permeability, and it operates in both developmental and pathological contexts. Since its discovery, VEGF signaling has become one of the most intensively studied pathways in vascular biology, with broad implications for cancer, ophthalmology, and regenerative medicine. Researchers investigating endothelial cell behavior, tumor angiogenesis, or vascular normalization rely on precise understanding of this pathway to design experiments and interpret phenotypic outcomes. The pathway is also a prime example of how receptor tyrosine kinase signaling integrates multiple downstream cascades to produce context-dependent cellular responses. This article synthesizes authoritative GO annotation and published literature to provide a research-grade overview of GO:0038084, its molecular components, regulatory mechanisms, disease relevance, and experimental strategies for study.
vascular endothelial growth factor signaling pathway At A Glance
| GO ID | GO:0038084 |
|---|---|
| GO term | vascular endothelial growth factor signaling pathway |
| Ontology | biological_process |
| Synonym | vascular endothelial growth factor signalling pathway; VEGF-activated signaling pathway; VEGF signaling |
| Definition | The series of molecular signals initiated by vascular endothelial growth factor (VEGF) binding its receptor on the surface of the target cell, and ending with the regulation of a downstream cellular process, e.g. transcription. |
| Major function | Regulation of angiogenesis, vascular permeability, endothelial cell proliferation, migration, and survival |
| Key ligands | VEGFA, VEGFB, VEGFC, VEGFD, PlGF |
| Key receptors | VEGFR1 (FLT1), VEGFR2 (KDR), VEGFR3 (FLT4) |
| Downstream pathways | PLCγ-PKC-ERK1/2, PI3K-AKT-eNOS, Src-FAK, p38 MAPK |
What Is GO:0038084?
GO:0038084, the vascular endothelial growth factor signaling pathway, is defined in QuickGO as the series of molecular signals initiated by vascular endothelial growth factor (VEGF) binding its receptor on the surface of the target cell, and ending with the regulation of a downstream cellular process, e.g. transcription. In simpler terms, it is the entire communication chain that starts when VEGF docks onto its receptor and finishes with changes in how the cell behaves or which genes it turns on or off. This process is a biological_process in the Gene Ontology and encompasses ligand-receptor interaction, receptor activation, intracellular signal transduction, and downstream transcriptional or non-transcriptional responses.
Why Is vascular endothelial growth factor signaling pathway Important in Cell Biology?
GO:0038084 is critically important because VEGF signaling is the principal pathway controlling blood vessel formation and function, and its dysregulation underlies numerous human diseases including cancer, diabetic retinopathy, and inflammatory disorders. Understanding this pathway at molecular resolution is essential for developing anti-angiogenic therapies and for interpreting how tumors and ischemic tissues respond to VEGF blockade. Moreover, the pathway serves as a paradigm for receptor tyrosine kinase signal integration, making it a frequent subject of basic cell biology research.
• Controls embryonic vascular development and adult physiological angiogenesis.
• Drives tumor angiogenesis and is a major target for anti-cancer therapeutics.
• Regulates vascular permeability and is implicated in edema and inflammation.
• Plays a role in liver regeneration through effects on sinusoidal endothelial cells.
• Is modulated by microRNAs during vascular development.
• Involved in lymphangiogenesis via VEGFR3 signaling.
• Serves as a model for receptor tyrosine kinase signaling mechanisms.
• Dysregulation contributes to retinopathies and age-related macular degeneration.
• Provides targets for CRISPR-based functional genomics in endothelial cells.
• Has therapeutic relevance in ischemic disease and tissue repair.
What Happens During vascular endothelial growth factor signaling pathway?
Ligand binding and receptor activation
In simple terms: VEGF molecules attach to receptors on the cell surface, causing the receptors to pair up and become active.
The pathway begins when VEGF ligands, including VEGFA, VEGFB, VEGFC, VEGFD, and PlGF, bind to their cognate receptor tyrosine kinases VEGFR1, VEGFR2, or VEGFR3 on the surface of target cells. Ligand binding induces receptor dimerization and autophosphorylation of specific tyrosine residues in the intracellular kinase domain, which creates docking sites for downstream signaling proteins. VEGFR2 is considered the major mediator of angiogenic signaling in endothelial cells, while VEGFR1 modulates signaling and VEGFR3 primarily mediates lymphangiogenesis.
PLCγ-PKC-ERK1/2 cascade
In simple terms: Activated receptors turn on a series of enzymes that ultimately stimulate cell division and growth.
Phosphorylated VEGFR2 recruits phospholipase C gamma (PLCγ), which hydrolyzes PIP2 to generate IP3 and DAG. DAG activates protein kinase C (PKC), leading to activation of the RAF-MEK-ERK1/2 kinase cascade. ERK1/2 translocates to the nucleus and regulates transcription factors that drive endothelial cell proliferation and migration. This cascade is a central output of VEGF signaling and is frequently targeted in experimental studies of angiogenesis.
PI3K-AKT-eNOS signaling
In simple terms: Another branch of the pathway promotes cell survival and produces nitric oxide to relax blood vessels.
VEGFR2 activation also recruits PI3K, which generates PIP3 and activates AKT. AKT promotes endothelial cell survival and activates endothelial nitric oxide synthase (eNOS), increasing nitric oxide production and vascular permeability. This arm of the pathway is critical for VEGF-induced vasodilation and survival signaling, and its dysregulation contributes to pathological vascular leakage.
Src-FAK and cytoskeletal remodeling
In simple terms: VEGF signaling also reorganizes the cell's internal skeleton to help cells move and form new vessels.
VEGF stimulation activates Src family kinases and focal adhesion kinase (FAK), which regulate cytoskeletal dynamics and cell migration. These signals are essential for endothelial cell sprouting and tube formation during angiogenesis. Src-mediated phosphorylation of junctional proteins also contributes to increased vascular permeability.
Transcriptional regulation and feedback
In simple terms: The pathway changes which genes are turned on, including genes that can feed back to tune the signal.
Downstream kinase cascades activate transcription factors such as NFAT, ETS, and STAT family members, leading to changes in gene expression that support angiogenesis and vascular remodeling. MicroRNAs also modulate VEGF signaling output during vascular development, providing an additional layer of post-transcriptional control. Feedback mechanisms, including receptor internalization and phosphatase activity, ensure that signaling is appropriately terminated.
Key Genes Involved in GO:0038084 vascular endothelial growth factor signaling pathway
The following genes and proteins are core components or regulators of the vascular endothelial growth factor signaling pathway (GO:0038084), based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| VEGFA | Primary ligand for VEGFR2; drives angiogenesis and permeability | Most studied VEGF family member; target for anti-angiogenic therapy |
| VEGFB | Ligand for VEGFR1; involved in lipid metabolism and cardiac function | Less characterized; potential metabolic roles |
| VEGFC | Ligand for VEGFR3; promotes lymphangiogenesis | Key regulator of lymphatic development |
| VEGFD | Ligand for VEGFR3; lymphangiogenic factor | Studied in lymphatic disorders and tumor metastasis |
| PGF (PlGF) | Ligand for VEGFR1; modulates angiogenesis | Implicated in pathological angiogenesis |
| FLT1 (VEGFR1) | Receptor tyrosine kinase; modulates VEGF signaling | Decoy or signaling receptor depending on context |
| KDR (VEGFR2) | Principal receptor mediating angiogenic signaling | Central node for endothelial cell responses |
| FLT4 (VEGFR3) | Receptor for VEGFC/VEGFD; lymphangiogenesis | Target in lymphatic research |
| PLCG1 | Phospholipase C gamma; activates PKC-ERK cascade | Key downstream effector of VEGFR2 |
| PRKCA | Protein kinase C alpha; mediates DAG signaling | Involved in endothelial proliferation |
| MAPK1 (ERK2) | Kinase in RAF-MEK-ERK cascade | Drives transcriptional responses |
| MAPK3 (ERK1) | Kinase in RAF-MEK-ERK cascade | Drives transcriptional responses |
| PIK3CA | PI3K catalytic subunit; activates AKT | Promotes survival and eNOS activation |
| AKT1 | Serine/threonine kinase; survival and eNOS activation | Central node in VEGF survival signaling |
| NOS3 (eNOS) | Endothelial nitric oxide synthase; produces NO | Regulates vascular tone and permeability |
| SRC | Non-receptor tyrosine kinase; cytoskeletal regulation | Mediates permeability and migration |
| PTK2 (FAK) | Focal adhesion kinase; regulates migration | Involved in sprouting angiogenesis |
How Is vascular endothelial growth factor signaling pathway Regulated?
VEGF signaling is tightly regulated at multiple levels. Receptor availability and activity are controlled by internalization, degradation, and dephosphorylation. MicroRNAs fine-tune VEGF signaling output during vascular development, acting as post-transcriptional regulators. Additionally, feedback loops involving phosphatases and negative regulators ensure that signaling is transient and context-appropriate. In pathological states, this regulation is often disrupted, leading to sustained angiogenesis.
vascular endothelial growth factor signaling pathway and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| VEGFA | Tumor angiogenesis; retinopathy | Xenograft tumor models; oxygen-induced retinopathy |
| KDR (VEGFR2) | Angiogenesis; vascular permeability | Endothelial cell knockout; zebrafish models |
| FLT1 (VEGFR1) | Modulation of angiogenesis; preeclampsia | Conditional knockout mice |
| FLT4 (VEGFR3) | Lymphedema; lymphangiogenesis | Lymphatic endothelial cell models |
| NOS3 (eNOS) | Vascular tone; hypertension | Endothelial-specific knockout |
Cancer and tumor angiogenesis
VEGF signaling is a hallmark of tumor angiogenesis, where cancer cells secrete VEGF to promote new blood vessel formation and support tumor growth. Anti-VEGF therapies, including monoclonal antibodies and receptor kinase inhibitors, are used clinically in multiple cancers. Dysregulated VEGF signaling also contributes to tumor metastasis and vascular permeability.
Ocular diseases and retinopathies
Excessive VEGF signaling drives pathological angiogenesis in diabetic retinopathy, age-related macular degeneration, and retinopathy of prematurity. Anti-VEGF agents are standard of care for these conditions. Experimental models often use oxygen-induced retinopathy to study VEGF pathway contributions.
Liver regeneration and sinusoidal endothelial cells
The VEGF signaling pathway regulates liver sinusoidal endothelial cells during liver regeneration after partial hepatectomy, highlighting its role in organ repair. This context demonstrates that VEGF signaling extends beyond classical angiogenesis to tissue-specific regenerative processes.
Inflammatory and vascular permeability disorders
VEGF signaling increases vascular permeability and contributes to edema in inflammatory conditions. Src-mediated junctional changes are particularly important in this context. Targeting this arm of the pathway is an area of active research.
From vascular endothelial growth factor signaling pathway-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does a candidate gene mediate VEGF-induced proliferation? | CRISPR knockout in endothelial cells followed by VEGF stimulation |
| Does a point mutation in VEGFR2 alter kinase activity? | CRISPR point mutation knock-in in endothelial cell lines |
| Does a tag affect VEGFR2 trafficking? | Tagged knock-in of KDR in endothelial cells |
| Does overexpression of VEGFA increase angiogenesis? | CRISPR overexpression or lentiviral overexpression in endothelial cells |
| Which genes are essential for VEGF signaling? | CRISPR library screening in endothelial cells under VEGF stimulation |
| Does a microRNA regulate VEGF output? | Knockout or overexpression of miRNA in vascular development models |
How to Study the vascular endothelial growth factor signaling pathway Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Transcriptional changes | Identify VEGF target genes |
| Phosphoproteomics | Phosphorylation events | Map signaling cascades |
| Western blot | Protein expression and phosphorylation | Validate specific pathway nodes |
| Tube formation assay | Angiogenic capacity in vitro | Assess functional outcomes |
| CRISPR knockout | Gene function | Test causal roles in VEGF signaling |
| CRISPR library screen | Pooled gene function | Discover novel regulators |
| Intravital imaging | Vascular dynamics in vivo | Study angiogenesis in live animals |
Transcriptomic profiling
RNA-seq can measure global transcriptional changes downstream of VEGF signaling, identifying target genes and pathways. This approach is useful for comparing wild-type and knockout endothelial cells after VEGF stimulation.
Phosphoproteomics
Mass spectrometry-based phosphoproteomics can map receptor autophosphorylation sites and downstream kinase cascades activated by VEGF. This method provides a global view of signaling dynamics.
Imaging and functional assays
Endothelial tube formation, sprouting assays, and intravital imaging can assess angiogenic outcomes of VEGF signaling. These functional readouts complement molecular analyses.
CRISPR screening
Pooled CRISPR screens can identify genes that modulate VEGF signaling output, revealing novel regulators and therapeutic targets. This approach is powerful for unbiased discovery.
How CRISPR Can Be Used to Study GO:0038084 vascular endothelial growth factor signaling pathway
Knockout
CRISPR knockout of VEGF pathway genes, such as KDR or VEGFA, in endothelial cells or animal models can reveal their essential functions in angiogenesis and vascular development. Knockout studies have confirmed the requirement of VEGFR2 for VEGF-induced proliferation and migration.
Point Mutation
CRISPR point mutation knock-in can introduce specific amino acid substitutions in receptors or downstream kinases to dissect domain functions, such as kinase activity or docking site requirements. This approach is valuable for structure-function studies of VEGFR2.
Knock-in
Tagged knock-in of pathway components, such as fluorescently labeled VEGFR2, enables real-time imaging of receptor trafficking and signaling dynamics in live cells. Knock-in of reporter genes can also monitor transcriptional outputs.
Overexpression
CRISPR-mediated overexpression or lentiviral overexpression of VEGF ligands or receptors can amplify pathway activity and model pathological states such as tumor angiogenesis. Overexpression models are useful for gain-of-function studies.
How EDITGENE Supports vascular endothelial growth factor signaling pathway Research
Researchers studying vascular endothelial growth factor signaling pathway-related genes often need to determine whether a candidate gene is causally involved in pathway output, and CRISPR-based models provide a precise way to test this. By combining knockout, point mutation, knock-in, and overexpression strategies, it is possible to dissect the contribution of individual components to angiogenesis and vascular biology.
Contact EDITGENE today to design your custom CRISPR model for vascular endothelial growth factor signaling pathway research.
Frequently Asked Questions About vascular endothelial growth factor signaling pathway
What is the vascular endothelial growth factor signaling pathway?
It is the series of molecular signals initiated by VEGF binding its receptor on the cell surface, leading to regulation of downstream cellular processes such as transcription (GO:0038084).
What genes are involved in VEGF signaling?
Key genes include VEGFA, VEGFB, VEGFC, VEGFD, PGF, FLT1, KDR, FLT4, PLCG1, PIK3CA, AKT1, NOS3, SRC, and PTK2.
What is the role of VEGFR2 in VEGF signaling?
VEGFR2 (KDR) is the principal receptor mediating angiogenic signaling, including endothelial cell proliferation, migration, and survival.
How is VEGF signaling regulated?
It is regulated by receptor internalization, phosphatases, microRNAs, and feedback loops that ensure transient signaling.
What diseases are associated with VEGF signaling?
Cancer, diabetic retinopathy, age-related macular degeneration, inflammatory disorders, and liver regeneration defects.
How can CRISPR be used to study VEGF signaling?
CRISPR knockout, point mutation, knock-in, and overexpression models allow causal dissection of pathway components in endothelial cells.
What is the GO ID for VEGF signaling?
GO:0038084, vascular endothelial growth factor signaling pathway.
What are the downstream pathways of VEGF signaling?
PLCγ-PKC-ERK1/2, PI3K-AKT-eNOS, and Src-FAK cascades are major downstream branches.
Why is VEGF signaling important in cancer?
It drives tumor angiogenesis, supporting tumor growth and metastasis, and is a target for anti-angiogenic therapies.
What experimental models are used to study VEGF signaling?
Endothelial cell culture, zebrafish, mouse models, and CRISPR-engineered cell lines are commonly used.
Conclusion
GO:0038084, the vascular endothelial growth factor signaling pathway, is a fundamental biological process that controls angiogenesis, vascular permeability, and endothelial cell behavior through a well-defined cascade of ligand-receptor interactions and downstream kinases. Its dysregulation is central to cancer, ocular diseases, and inflammatory conditions, making it a prime target for therapeutic intervention and basic research. Advances in CRISPR-based models and functional genomics continue to refine our understanding of this pathway, offering new opportunities to dissect mechanism and identify drug targets.
References
- 1. Apte RS et al.. 2019. VEGF in Signaling and Disease: Beyond Discovery and Development.. Cell 176(6):1248-1264 PMID: 30849371
- 2. Karaman S et al.. 2018. Vascular endothelial growth factor signaling in development and disease.. Development 145(14) PMID: 30030240
- 3. Lu J et al.. 2021. The vascular endothelial growth factor signaling pathway regulates liver sinusoidal endothelial cells during liver regeneration after partial hepatectomy.. Expert Rev Gastroenterol Hepatol 15(2):139-147 PMID: 32902336
- 4. Ferrara N et al.. 2003. The biology of VEGF and its receptors.. Nat Med 9(6):669-76 PMID: 12778165
- 5. Simons M et al.. 2016. Mechanisms and regulation of endothelial VEGF receptor signalling.. Nat Rev Mol Cell Biol 17(10):611-25 PMID: 27461391
- 6. Kowanetz M et al.. 2006. Vascular endothelial growth factor signaling pathways: therapeutic perspective.. Clin Cancer Res 12(17):5018-22 PMID: 16951216
- 7. Larrivée B et al.. 2000. Signaling pathways induced by vascular endothelial growth factor (review).. Int J Mol Med 5(5):447-56 PMID: 10762646
- 8. Dang LT et al.. 2013. MicroRNA control of vascular endothelial growth factor signaling output during vascular development.. Arterioscler Thromb Vasc Biol 33(2):193-200 PMID: 23325476
